洲鎌 秀永

論文

• Noradrenaline as a key neurotransmitter in modulating microglial activation in stress response

  Shuei Sugama, Yoshihiko Kakinuma

  Neurochemistry International 143 104943-104943 2021年2月
• Possible Role of Activin in the Adiponectin Paradox-Induced Progress of Alzheimer's Disease.

  Makoto Hashimoto, Gilbert Ho, Shuei Sugama, Takato Takenouchi, Masaaki Waragai, Hiromu Sugino, Satoshi Inoue, Eliezer Masliah

  Journal of Alzheimer's disease : JAD 81(2) 451-458 2021年
• Understanding Creutzfeldt-Jackob disease from a viewpoint of amyloidogenic evolvability.

  Makoto Hashimoto, Gilbert Ho, Yoshiki Takamatsu, Ryoko Wada, Shuei Sugama, Masaaki Waragai, Eliezer Masliah, Takato Takenouchi

  Prion 14(1) 1-8 2020年12月
• Stress and brain immunity: Microglial homeostasis through hypothalamus-pituitary-adrenal gland axis and sympathetic nervous system

  Sugama S, Kakinuma Y

  Brain Behavior Immunity-Health 100111 2020年7月 査読有り筆頭著者
• Connecting Alzheimer's Disease With Diabetes Mellitus Through Amyloidogenic Evolvability.

  Gilbert Ho, Yoshiki Takamatsu, Ryoko Wada, Shuei Sugama, Masaaki Waragai, Takato Takenouchi, Eliezer Masliah, Makoto Hashimoto

  Frontiers in aging neuroscience 12 576192-576192 2020年
• Adiponectin Paradox in Alzheimer's Disease; Relevance to Amyloidogenic Evolvability?

  Masaaki Waragai, Gilbert Ho, Yoshiki Takamatsu, Ryoko Wada, Shuei Sugama, Takato Takenouchi, Eliezer Masliah, Makoto Hashimoto

  Frontiers in endocrinology 11 108-108 2020年
• Adiponectin Paradox as a Therapeutic Target in Alzheimer's Disease.

  Masaaki Waragai, Gilbert Ho, Yoshiki Takamatsu, Ryoko Wada, Shuei Sugama, Takato Takenouchi, Eliezer Masliah, Makoto Hashimoto

  Journal of Alzheimer's disease : JAD 76(4) 1249-1253 2020年
• Stress-induced microglial activation occurs through β-adrenergic receptor: Noradrenaline as a key neurotransmitter in microglial activation

  Sugama S, Takenouchi T, Hashimoto M, Ohata H, Takenaka H, Kakinuma Y

  Journal of Neuroinflammation 2019年11月 査読有り筆頭著者
• Current and future clinical utilities of Parkinson's Disease and dementia biomarkers: can they help us conquer the disease?

  Ho G, Takamatsu Y, Waragai M, Wada R, Sugama S, Takenouchi T, Fujita M, Ali A, Hsieh MH, Hashimoto M

  Expert review of neurotherapeutics 19(11) 1149-1161 2019年7月 査読有り
• Potentiating a non-neuronal cardiac cholinergic system reinforces the functional integrity of the blood brain barrier associated with systemic anti-inflammatory responses

  Oikawa S, Kai Y, Mano A, Sugama S, Mizoguchi N, Tsuda M, Muramoto K, Kakinuma Y

  81 122-137 2019年6月 査読有り
• Possible Role of Amyloid Cross-Seeding in Evolvability and Neurodegenerative Disease.

  Makoto Hashimoto, Gilbert Ho, Yoshiki Takamatsu, Ryoko Wada, Shuei Sugama, Takato Takenouchi, Masaaki Waragai, Eliezer Masliah

  Journal of Parkinson's disease 9(4) 793-802 2019年
• Transgenerational Interaction of Alzheimer's Disease with Schizophrenia through Amyloid Evolvability.

  Takamatsu Y, Ho G, Waragai M, Wada R, Sugama S, Takenouchi T, Masliah E, Hashimoto M

  Journal of Alzheimer's disease : JAD 68(2) 473-481 2019年 査読有り
• Dual-therapy strategy for modification of adiponectin receptor signaling in aging-associated chronic diseases

  Masaaki Waragai, Gilbert Ho, Yoshiki Takamatsu, Yuka Shimizu, Hiromu Sugino, Shuei Sugama, Takato Takenouchi, Eliezer Masliah, Makoto Hashimoto

  Drug Discovery Today 23(6) 1305-1311 2018年6月1日 査読有り
• Motor and Nonmotor Symptoms of Parkinson's Disease: Antagonistic Pleiotropy Phenomena Derived from α-Synuclein Evolvability?

  Takamatsu Y, Fujita M, Ho GJ, Wada R, Sugama S, Takenouchi T, Waragai M, Masliah E, Hashimoto M

  Parkinson's disease 2018 5789424-5789424 2018年 査読有り
• Possible Role of the Polyglutamine Elongation in Evolution of Amyloid-Related Evolvability.

  Hashimoto M, Ho G, Takamatsu Y, Wada R, Sugama S, Takenouchi T, Masliah E, Waragai M

  Journal of Huntington's disease 7(4) 297-307 2018年 査読有り
• Evolvability and Neurodegenerative Disease: Antagonistic Pleiotropy Phenomena Derived from Amyloid Aggregates.

  Hashimoto M, Ho G, Takamatsu Y, Shimizu Y, Sugama S, Takenouchi T, Waragai M, Masliah E

  J Parkinsons Dis 8(3) 405-408 2018年 査読有り
• Evolvability of Amyloidogenic Proteins in Human Brain

  Makoto Hashimoto, Gilbert Ho, Shuei Sugama, Yoshiki Takamatsu, Yuka Shimizu, Takato Takenouchi, Masaaki Waragai, Eliezer Masliah

  Journal of Alzheimer's Disease 62(1) 73-83 2018年 査読有り
• Potential Application of Centrifuges to Protect the CNS in Space and on Earth.

  Hashimoto M, Ho G, Shimizu Y, Sugama S, Takenouchi T, Waragai M, Wei J, Takamatsu Y

  Curr Alzheimer Res 15(6) 544-551 2018年 査読有り
• Importance of adiponectin activity in the pathogenesis of Alzheimer's disease.

  Waragai M, Ho G, Takamatsu Y, Sekiyama K, Sugama S, Takenouchi T, Masliah E, Hashimoto M

  Ann Clin Transl Neurol 4(8) 591-600 2017年7月 査読有り
• Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress.

  Mori S, Sugama S, Nguyen W, Michel T, Sanna MG, Sanchez-Alavez M, Cintron-Colon R, Moroncini G, Kakinuma Y, Maher P …

  J Neuroinflammation 14(1) 88 2017年4月 査読有り